240108建仓,成本5.968刀
目标12刀, 计划持有周期6~12个月.查看全文
蹊之美股生物医药2021-08-19 21:20
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
PharmaCyte Biotech (NASDAQ:PMCB) +189%
Virpax Pharmaceuticals (NASDAQ:VRPX) +49%
Allied Healthcare Properties (NASDAQ:AHPI) +12%
BrainsWay (NASDAQ:BWAY) +10%
Regional...查看全文
古室长2021-08-18 21:18
【美股盘前要闻一览】
盘前三大指数小幅下跌。美联储主席鲍威尔在昨日的线上市政厅会议上表达了对德尔塔毒株的担忧,他承认,经济活动仍然处在疫情的阴影下,现在还不是宣布胜利的时候
1、TCEHY,腾讯ADR,盘前涨3.45%,腾讯二季度财报超预期,并首次披露小学生游戏流水占比0.3%
2、DI...查看全文
7X24快讯2021-08-18 19:44
医疗设备公司Brainsway(BWAY.O)盘前涨近21%,此前其用于减轻抑郁症患者焦虑症状的Deep TMS系统获得美国食品药品监督管理局批准。查看全文
美股大观2021-04-21 22:09
我们是一家商业阶段的医疗设备公司,致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。我们新颖独特的RNS系统是首个也是唯一一个可商用的大脑反应性神经调节系统,可在癫痫发作源提供个性化的实时治疗。通过持续监控大脑的电活动,识别患者特定的异常电模式并以不可察觉的电脉冲实时...查看全文
一年交易一次2020-03-13 09:48
23日拟披露2019年四季度业绩。$Brainsway(BWAY)$ PATTERSON, N.J., March 11, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it wi...查看全文
美柏医健2020-02-21 14:03
《柳叶刀》:新闻&社交媒体助力新冠肺炎流行病学研究
研究背景
随着新冠肺炎(COVID-19)疫情的进展,我们亟需流行病学数据来指导疫情态势评估和干预策略。
近日,发表于《柳叶刀》子刊《The Lancet·Digital Health》的一篇研究,描述了从新闻媒体和社交网络收集和分析得出的COVID...查看全文
$Brainsway(BWAY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001178913-23-000585 Act: 34 Size: 70 KB 网页链接
$Brainsway(BWAY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-23-001341 Act: 34 Size: 107 KB 网页链接
$Brainsway(BWAY)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-23-000928 Act: 34 Size: 151 KB 网页链接
$Brainsway(BWAY)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-23-000922 Act: 34 Size: 13 KB 网页链接
$Brainsway(BWAY)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-23-000923 Act: 34 Size: 14 KB 网页链接
$Brainsway(BWAY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001085146-23-000178 Act: 34 Size: 27 KB 网页链接
$Brainsway(BWAY)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-23-000226 Act: 34 Size: 18 KB 网页链接
$Brainsway(BWAY)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-23-000174 Act: 34 Size: 11 KB 网页链接
$Brainsway(BWAY)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001171843-22-007748 Act: 34 Size: 32 KB 网页链接
$Brainsway(BWAY)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001171843-22-007749 Act: 34 Size: 31 KB 网页链接